Simcere teams up with Sun Yat-Sen University for oncology drug development, GBI

Release Date: 2009-08-25

Simcere Pharmaceutical Group (NYSE: SCR) has formed a strategic partnership with the Sun Yat-Sen University Cancer Center for anti-cancer drug research and development and R&D personnel training, according to PRNewswire August 24.

Simcere is a leading pharmaceutical company in China focused on manufacturing, marketing, and research and development of branded generic as well as innovative pharmaceuticals.

Sun Yat-Sen University (Zhongshan University) is located in Guangzhou, Guangdong Province. Its cancer center is one of the nation's leading cancer research institutes and serves as a base for pre-clinical and clinical cancer research.
Type: NORMAL
Company: GBI
Country: China
Url: http://www.gbipharma.com/cpbheadline.asp?newsid=2010482
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.